SCHEMBL27134019

SCHEMBL27134019

CC(C)C1CC2C(C)CC1C(OC(=O)c1ccccc1)C2OC(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 1/20 0.50
▸ CHRNA7 P36544 2/20 0.44
▸ HTR3E A5X5Y0 1/20 0.44
▸ HTR3B O95264 1/20 0.44
▸ HTR3A P46098 1/20 0.44
▸ HTR3D Q70Z44 1/20 0.44
▸ HTR3C Q8WXA8 1/20 0.44
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ APOBEC3A P31941 1/20 0.40
▸ APOBEC3G Q9HC16 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27134282 0.89 CHRNA7 (0.49) TRPM8CHRNA7HTR3EHTR3BHTR3A
SCHEMBL27134022 0.80 TRPM8 (0.49) TRPM8CHRNA7HTR3EHTR3BHTR3A
SCHEMBL27052185 0.80 CHRNA7 (0.47) TRPM8CHRNA7HTR3EHTR3BHTR3A
SCHEMBL27134290 0.80 MAPK1 (0.42) TRPM8CHRNA7HTR3EHTR3BHTR3A
SCHEMBL27052545 0.76 CHRNA7 (0.46) TRPM8CHRNA7HTR3EHTR3BHTR3A
SCHEMBL27134021 0.75 CHRNA7 (0.46) TRPM8CHRNA7HTR3EHTR3BHTR3A
SCHEMBL27052186 0.74 CHRNA7 (0.48) TRPM8CHRNA7HTR3EHTR3BHTR3A
Menthyl Benzoate SCHEMBL15498193 0.74 ALDH1A1 (0.69) TRPM8CHRM2CHRM4CHRM1CHRM3
Menthyl Benzoate SCHEMBL3885473 0.74 ALDH1A1 (0.69) TRPM8CHRM2CHRM4CHRM1CHRM3
Menthyl Benzoate SCHEMBL18708099 0.74 ALDH1A1 (0.69) TRPM8CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067764-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER MITSUI CHEMICALS, INC. (JP) 2024-02-29 — — US disclosed
US-20240067597-A1 ESTER COMPOUND MITSUI CHEMICALS, INC. (JP) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067597-A1 ESTER COMPOUND PPT1, GPER1, TCP1 TRPM8 4752/4885CHRNA7 2463/4885HTR3E 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback